- Home
- RMBI vs GNLX Comparison
RMBI vs GNLX Comparison
Compare RMBI & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBI
- GNLX
- Stock Information
- Founded
- RMBI 1887
- GNLX 2001
- Country
- RMBI United States
- GNLX United States
- Employees
- RMBI N/A
- GNLX N/A
- Industry
- RMBI Major Banks
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- RMBI Finance
- GNLX Health Care
- Exchange
- RMBI Nasdaq
- GNLX Nasdaq
- Market Cap
- RMBI 139.0M
- GNLX 112.5M
- IPO Year
- RMBI 2019
- GNLX 2023
- Fundamental
- Price
- RMBI $13.54
- GNLX $3.44
- Analyst Decision
- RMBI
- GNLX Strong Buy
- Analyst Count
- RMBI 0
- GNLX 4
- Target Price
- RMBI N/A
- GNLX $17.75
- AVG Volume (30 Days)
- RMBI 95.3K
- GNLX 152.2K
- Earning Date
- RMBI 07-24-2025
- GNLX 08-13-2025
- Dividend Yield
- RMBI 4.35%
- GNLX N/A
- EPS Growth
- RMBI 2.54
- GNLX N/A
- EPS
- RMBI 0.89
- GNLX N/A
- Revenue
- RMBI $42,825,687.00
- GNLX N/A
- Revenue This Year
- RMBI N/A
- GNLX N/A
- Revenue Next Year
- RMBI N/A
- GNLX N/A
- P/E Ratio
- RMBI $15.51
- GNLX N/A
- Revenue Growth
- RMBI 2.64
- GNLX N/A
- 52 Week Low
- RMBI $11.33
- GNLX $1.60
- 52 Week High
- RMBI $15.15
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- RMBI 46.71
- GNLX 65.71
- Support Level
- RMBI $13.61
- GNLX $2.80
- Resistance Level
- RMBI $14.09
- GNLX $3.61
- Average True Range (ATR)
- RMBI 0.45
- GNLX 0.22
- MACD
- RMBI 0.01
- GNLX 0.05
- Stochastic Oscillator
- RMBI 42.22
- GNLX 80.23
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.